Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Signing Day Sports Launches Dietary Supplements Line for Student-Athletes
-
New Research From Winterberry Group Explores Artificial Intelligence and its Role in Transforming Video and Content Production
-
LiveOne (Nasdaq: LVO) Appoints Aaron Sullivan as CFO
-
CUSIP Global Services Assumes Administration of Card Issuer Identification Numbering System
-
CVR Energy to Release Fourth Quarter and Full-Year 2023 Earnings Results
-
CVR Partners to Release Fourth Quarter and Full-Year 2023 Earnings Results
-
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Biodexa Announces Allowance of U.S. Patent Covering Tolimidone
-
Equinor ASA: Notifiable trading
-
Avant Technologies, Inc. Appoints Seasoned Technology Operations Leader Angela Harris as Chief Operating Officer
-
Statement from US Cement Industry Regarding EPA's Particulate Matter Standard
-
Statement from US Cement Industry Regarding EPA's Particulate Matter Standard
-
Form 8.3 - Young & Co's Brewery plc
-
Ensemble Health Partners Receives “Best in KLAS” Designation for Full Revenue Cycle Outsourcing for Fourth Time
-
BEZTAK AWARDED PROPERTY MANAGEMENT FIRM OF THE YEAR BY RE JOURNALS
-
MatrixCare Earns Three 2024 Best in KLAS Awards
-
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
-
EnergyX is Acquired by Apogee Interactive to Enhance Platform That Improves Energy Savings Programs for Utilities
-
Riverside Acceleration Capital (RAC) Closes RAC Opportunity Fund II, L.P. at $235 Million
-
Several Staffing 360 Solutions Brands Receive Awards for Exceptional Client Service
-
Circana Launches Liquid Data Engage, Propelling Retailers Into a New Era of Decision-Making
-
Century Announces Filing of Third Quarter Financial Results and Management Discussion and Analysis for Nine Months Ended December 31, 2023, Changes of its Board of Directors and its Auditor
-
Verde appoints João Paulo Frez as Chief Revenue Officer
-
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the 2024 BIO CEO & Investor Conference to Provide Corporate Update and Discuss Key Milestones
-
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the 2024 BIO CEO & Investor Conference to Provide Corporate Update and Discuss Key Milestones
-
DIVA DISC WINS PRODUCT OF THE YEAR CANADA AWARD
-
Nextech Named 2024 Best in KLAS: Ambulatory Specialty EHR
-
Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
-
TTM Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Results
-
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
-
Vortex Energy Corp. Provides Update on Drilling at the Robinsons River Salt Project
-
Cheetah Net Supply Chain Service Inc. Completes Edward Acquisition
-
One month left to submit a claim under the First Nations Drinking Water Settlement
-
Aqua-Tots Swim School Prepares to Dive into Beachfront Town of Holland, Michigan
-
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
-
Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer
-
R1 Wins Multiple Best in KLAS Awards for Third Straight Year
-
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
FM Capital Names Jake Sigal & Massimo Baldini Technology Operating Partners
-
Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Panc
-
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Stryker declares a $0.80 per share quarterly dividend
-
Twin Disc Announces Second Quarter Results
-
Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company
-
CarbonBuilt Names Michelle Carvin, CFA as the Company’s Chief Financial Officer
-
Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program
-
Nékter Juice Bar Partners with Qu to Unify Ordering Channels and Drive Sustainable Growth as it Continues Nationwide Expansion
-
LifeVantage Announces Expansion of LV360 into Canada, Mexico, and European Markets
-
Helo Corp to Present at the Emerging Growth Conference on February 7, 2024
-
Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
